Lenalidomide is on a trial for the treatments of other types of cancer such as Hodgkin’s Lymphoma, non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, and solid tumor cancers. Celgene has conducted various trials in patients with B-cell chronic lymphocytic leukemia in July 2013. At that time the number of cancer deaths was observed at the time of treatment.